trending Market Intelligence /marketintelligence/en/news-insights/trending/kjCIHjapuy3wv1Lrg9UcpA2 content esgSubNav
In This List

Champions Oncology regains Nasdaq compliance

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Champions Oncology regains Nasdaq compliance

Champions Oncology Inc. said it received written confirmation from Nasdaq Stock Market that it regained compliance with the required minimum market value of listed securities.

The company's market value from Sept. 15 to Sept. 28 had been $35 million or greater, according to a Form 8-K filing.

In April, the company received a noncompliance notice from the regulator and was given until Oct. 23 to regain compliance.